Body Composition Calculator
A modern alternative to BMI alone. This calculator estimates cardiometabolic risk from four complementary metrics: waist-to-height ratio (WHtR), waist circumference, waist-to-hip ratio, and BMI. Each captures a different aspect of body composition, with ethnicity-specific cutoffs where validated. BMI alone misses where fat is distributed — and visceral (central) adiposity is what drives cardiometabolic risk, not body weight per se.
Cardiometabolic Risk Summary
--
--
Best single predictor of cardiometabolic risk. Universal target: keep your waist under half your height.
Reflects central adiposity. Cutoffs adjusted for sex and ethnicity.
Captures android (apple) vs gynoid (pear) fat distribution pattern.
Useful for population context but cannot distinguish fat from muscle, or where fat is stored.
--
Why Move Beyond BMI?
Body mass index (BMI) was developed by Adolphe Quetelet in 1832 as a population-level statistical tool — not as a clinical measure of individual health. While it remains widely used because of its simplicity, the limitations are now well recognised:
- Cannot distinguish fat from muscle. A muscular athlete and a sedentary person with significant fat can have the same BMI but very different cardiometabolic risk.
- Cannot identify fat distribution. Visceral (intra-abdominal) fat is far more harmful than subcutaneous fat. BMI is blind to where fat sits.
- Systematic ethnicity bias. BMI thresholds were derived from European populations. South and East Asian populations develop diabetes and cardiovascular disease at lower BMI values; Pacific Islanders may carry more lean mass at higher BMI.
- Sex and age bias. Women carry more body fat than men at the same BMI. Older adults lose lean mass and gain fat at stable BMI (sarcopenic obesity) — invisible to the metric.
- Doesn't predict outcomes well at the individual level. The "obesity paradox" — where patients with established cardiovascular disease and a BMI of 25–30 sometimes have better outcomes than those at a "normal" BMI — reflects this poor discrimination.
The 2023 American Medical Association resolution and the 2025 Lancet Commission on Clinical Obesity both formally recognised these limitations. Modern cardiometabolic risk assessment uses multiple metrics — not BMI alone.
What These Four Metrics Tell You
Waist-to-height ratio (WHtR) is the strongest single predictor of cardiometabolic outcomes in most populations. The principle is intuitive: keep your waist circumference under half your height. A WHtR of ≥0.5 indicates increased cardiometabolic risk across age, sex, and ethnic groups, with ≥0.6 indicating substantially elevated risk. Multiple meta-analyses have shown WHtR outperforms BMI and waist circumference alone for predicting diabetes, hypertension, cardiovascular disease, and all-cause mortality.
Waist circumference (WC) directly reflects central adiposity — the visceral fat that drives insulin resistance and cardiovascular risk. Cutoffs are ethnicity-specific because the relationship between waist size and metabolic risk differs between populations. For Europeans, increased risk begins at ≥94 cm (men) and ≥80 cm (women), with high risk at ≥102 cm and ≥88 cm respectively. For South and East Asian populations, the cutoffs are lower: ≥90 cm (men) and ≥80 cm (women) directly indicate increased risk.
Waist-to-hip ratio (WHR) captures the pattern of fat distribution — android (central, "apple-shaped") versus gynoid (peripheral, "pear-shaped"). Android obesity carries higher cardiometabolic risk independent of total body fat. WHO thresholds for increased risk are ≥0.90 for men and ≥0.85 for women.
BMI remains useful as a population-level metric and rough screening tool, but its limitations require it to be interpreted alongside the other metrics. Asia-Pacific BMI cutoffs (overweight ≥23, obese ≥25) are applied for South and East Asian populations, reflecting earlier cardiometabolic risk at lower BMI values.
How to Interpret the Overall Verdict
This calculator counts how many of the four metrics fall into elevated-risk categories, weighting WHtR most heavily because of its superior predictive validity. The overall verdict reflects the combined pattern:
- Low risk: All metrics in healthy ranges. Continue current lifestyle.
- Moderate risk: One metric elevated (usually WHtR or BMI alone). Consider lifestyle adjustments.
- Increased risk: Two or more metrics elevated, or WHtR ≥ 0.6. Discuss with your doctor about cardiovascular risk assessment.
- High risk: Most metrics elevated, with a pattern consistent with central obesity. Comprehensive cardiometabolic evaluation recommended.
If any metric indicates elevated risk, consider broader cardiovascular risk assessment using the PREVENT calculator, which incorporates these findings alongside lipids, blood pressure, kidney function, and metabolic status.
What This Calculator Cannot Tell You
No anthropometric tool replaces direct body composition measurement (DEXA, bioelectrical impedance, or air displacement plethysmography). These methods quantify fat mass, lean mass, and bone mineral content directly and are the gold standard in research and specialist settings. The metrics in this calculator are validated surrogates for use in everyday clinical and personal assessment.
This tool does not assess metabolic health independently — blood pressure, lipids, glucose, and inflammatory markers are required for a complete cardiometabolic profile. Two people with identical body composition can have different metabolic risk depending on these factors. The concept of metabolically healthy obesity versus metabolically unhealthy normal weight is well established and underscores the importance of looking beyond any anthropometric measure alone.
- Ashwell M, Gibson S. Waist-to-height ratio as an indicator of 'early health risk': simpler and more predictive than using a 'matrix' based on BMI and waist circumference. BMJ Open. 2016;6:e010159. doi:10.1136/bmjopen-2015-010159
- Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev. 2012;13(3):275–286. doi:10.1111/j.1467-789X.2011.00952.x
- Alberti KGMM, Eckel RH, Grundy SM, et al. Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the IDF Task Force on Epidemiology and Prevention; NHLBI; AHA; WHF; IAS; IASO. Circulation. 2009;120(16):1640–1645. doi:10.1161/CIRCULATIONAHA.109.192644
- World Health Organization. Waist Circumference and Waist-Hip Ratio: Report of a WHO Expert Consultation, Geneva, 8–11 December 2008. Geneva: WHO; 2011. WHO Publication
- WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157–163. doi:10.1016/S0140-6736(03)15268-3
- Rubino F, Cummings DE, Eckel RH, et al. Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol. 2025;13(3):221–262. doi:10.1016/S2213-8587(24)00316-4
- Ndumele CE, Rangaswami J, Chow SL, et al. Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association. Circulation. 2023;148(20):1606–1635. doi:10.1161/CIR.0000000000001184